“…72,75,[77][78][79] For these reasons, we recommend that all viable pregnancies, regardless of maternal stage, receive the first dose of BPG on a labor and delivery unit under continuous fetal monitoring with observation for at least 24 hours or until symptoms resolve. 72,77,80,81 However, lack of access to fetal monitoring should not delay timely maternal treatment. A discussion regarding symptoms of preterm labor or decreased fetal movement is encouraged in all women at the time of administration the first dose, especially if continuous fetal monitoring is not available.…”